Cerevel Therapeutics Holdings Inc (CERE)
42.07
+0.17
(+0.41%)
USD |
NASDAQ |
Apr 25, 16:00
42.10
+0.03
(+0.07%)
After-Hours: 20:00
Cerevel Therapeutics Holdings Net Income (TTM): -432.84M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -432.84M |
| September 30, 2023 | -392.99M |
| June 30, 2023 | -396.57M |
| March 31, 2023 | -387.50M |
| December 31, 2022 | -351.51M |
| September 30, 2022 | -317.76M |
| June 30, 2022 | -279.88M |
| Date | Value |
|---|---|
| March 31, 2022 | -242.65M |
| December 31, 2021 | -225.33M |
| September 30, 2021 | -199.46M |
| June 30, 2021 | -176.44M |
| March 31, 2021 | -149.92M |
| December 31, 2020 | -152.14M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-432.84M
Minimum
Dec 2023
-149.92M
Maximum
Mar 2021
-285.00M
Average
-279.88M
Median
Jun 2022
Net Income (TTM) Benchmarks
| AbbVie Inc | 4.863B |
| Immunogen Inc (DELISTED) | -73.52M |
| Bristol-Myers Squibb Co | 8.025B |
| Science 37 Holdings Inc (DELISTED) | -124.65M |
| Madrigal Pharmaceuticals Inc | -373.63M |